Gao Ankang1, Gao Eryuan1, Zhang Huiting2, Wang Shaoyu2, Yan Xu2, Bai Jie1, and Cheng Jingliang1
1Dept. of MRI, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China, 2MR Scientific Marketing, Siemens Healthcare, Shanghai, China, Shanghai, China
Synopsis
The
Isocitrate dehydrogenase (IDH) genotyping and epigenetic 1p/19q codeletion as
two key molecular markers are included in the glioma WHO 2016 classification. Gaussian
or non-Gaussian diffusion models were recently proposed to provide additional
microstructure information. In present work, we applied four diffusion models
in glioma grading and genotyping, including DTI, DKI, MAP-MRI and NODDI models,
which could be acquired within a single scan.
Background and Purpose
According to the
IDH and 1p/19q genetic status and prognosis of patients, gliomas could be divided
into 3 groups: IDH wild type, IDH mutant with 1p/19q uncodeleted, and IDH
mutant with 1p/19q codeleted [1]. Previous studies have proved apparent
diffusion coefficient (ADC) and Diffusion tensor imaging (DTI) are useful to
prediction of IDH [2,3]. Advanced diffusion models were recently proposed to
provide additional microstructure information [4]. This study aimed to evaluate
the performance of the 4 diffusion models in glioma genotyping, including
Diffusion tensor imaging (DTI), Diffusion kurtosis imaging (DKI), Mean apparent
propagator (MAP)-magnetic resonance imaging (MRI), and Neurite orientation
dispersion and density imaging (NODDI) models. A single and comprehensive
acquisition scheme was used for all the four models. Histogram features were
extracted from parameters of these diffusion models and used in genotyping of
glioma.Materials and Methods
Totally 99
patients were recruited, including grade II (n =
33), grade III (n = 11), or grade IV (n = 54) gliomas. In grade
II and III include IDH wild-type gliomas (n = 13), IDH-mutant with
1p/19q uncodeleted (n = 15), and IDH
mutant with 1p/19q codeleted (n = 16).
All the patients underwent diffusion weighted imaging (DWI) and conventional
MRI examinations on a 3T MR scanner (MAGNETOM Prisma, Siemens Healthcare,
Erlangen, Germany) with a 64 channel of head-neck coil. DWI was performed using
a spin-echo echo-planar imaging sequence and the parameters were: FOV = 220 ×
220 mm2, slice thickness = 2.0 mm, slice number = 66, TR/TE =
3700/72 ms, in-plane acceleration factor = 2, slice acceleration factor = 2,
diffusion time δ/Δ = 15.9/35.0 ms, two baseline (b=0) and 98 DWI data with
different diffusion directions and b-values were acquired using Cartesian-grid-sampling
scheme and bmax= 3000 s/mm2. The DTI, DKI, MAP, and NODDI parameters
were calculated using an in-house developed post-processing software called NeuDiLab,
which is based on an open-resource tool DIPY (Diffusion Imaging In Python,
http://nipy.org/dipy). The calculated parameters are listed in Table 1. The volume-of-interest
(VOI) was manually drawn around the entire tumor and peritumoral edema on axial
T2-Dark fluid images. The VOI were spatially transfer to the corresponding
diffusion parameters by rigid transformation between T2 and baseline diffusion
image.
The performance of
the feature was evaluated using receiver operating characteristic (ROC) curve
analysis and the area under the ROC curve (AUC). The diffusion parameters of
AUC >0.80 were accept.Results
For IDH type
differentiation in WHO grade II and III gliomas, the FA,
MSD skewness and NG values from DTI and MAP models outperformed the other
parameters of DKI or NODDI. When 1p/19q status were considered in IDH mutation
of WHO grade II and III gliomas, the
ICVF, MSD, QIV, and RTPP showed outstanding performance. For glioma grading, no
diffusion parameter showed AUC>0.80 in differentiating between grade III and IV. To
differentiating between grade III and IV, ICVF, RTOP and
RTAP showed relatively advantage. FA, MK, RK,
ICVF, NGax and NG are more important parameters in differentiating grade III and IV. The distribution
of mean and SD of useful parameters were shown as Figure 1.Discussion
MAP
diffusion model outperformed the other 3 models in differentiating between
genotype groups and different grading groups. Our research founded high
sensitivity of NODDI and MAP parameters in differentiating groups with
different 1p/19q gene status and IDH mutation, which is different to the
finding in Matteo Figini’s research [2]. Histogram analysis offer additional quantitative
information of the microstructure information.Conclusion
MAP as an advanced
diffusion model has more advantages than other models in
prediction of glioma Genotype. Histogram analysis
is a useful method in quantitative analysis of diffusion parameters and shows a
great potential in glioma research.Acknowledgements
noneReferences
1. Chen, Ricky, et al.
"Glioma Subclassifications and Their Clinical Significance." Neurotherapeutics 14.2(2017):1-14.
2. Figini,
Matteo et al. “Prediction of Isocitrate Dehydrogenase Genotype in Brain Gliomas
with MRI: Single-Shell versus Multishell Diffusion Models.” Radiology vol.
289,3 (2018): 788-796.
3. Maynard, John, et
al. "World Health Organization Grade II/III Glioma Molecular Status:
Prediction by MRI Morphologic Features and Apparent Diffusion
Coefficient." Radiology 296.1(2020):191832.
4. Avram, Alexandru V., et al, “Clinical feasibility
of using mean apparent propagator (MAP) MRI to characterize brain tissue
microstructure”, Neuroimage 127,(2016) 422–434